JP2019531763A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019531763A5 JP2019531763A5 JP2019533313A JP2019533313A JP2019531763A5 JP 2019531763 A5 JP2019531763 A5 JP 2019531763A5 JP 2019533313 A JP2019533313 A JP 2019533313A JP 2019533313 A JP2019533313 A JP 2019533313A JP 2019531763 A5 JP2019531763 A5 JP 2019531763A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- sequence
- site
- anchor sequence
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023113050A JP2023119040A (ja) | 2016-09-07 | 2023-07-10 | 遺伝子発現をモジュレートするための方法および組成物 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662384603P | 2016-09-07 | 2016-09-07 | |
| US62/384,603 | 2016-09-07 | ||
| US201662416501P | 2016-11-02 | 2016-11-02 | |
| US62/416,501 | 2016-11-02 | ||
| US201662439327P | 2016-12-27 | 2016-12-27 | |
| US62/439,327 | 2016-12-27 | ||
| US201762542703P | 2017-08-08 | 2017-08-08 | |
| US62/542,703 | 2017-08-08 | ||
| PCT/US2017/050553 WO2018049073A1 (en) | 2016-09-07 | 2017-09-07 | Methods and compositions for modulating gene expression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023113050A Division JP2023119040A (ja) | 2016-09-07 | 2023-07-10 | 遺伝子発現をモジュレートするための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019531763A JP2019531763A (ja) | 2019-11-07 |
| JP2019531763A5 true JP2019531763A5 (enExample) | 2020-10-22 |
| JP7682604B2 JP7682604B2 (ja) | 2025-05-26 |
Family
ID=61562240
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533313A Active JP7682604B2 (ja) | 2016-09-07 | 2017-09-07 | 遺伝子発現をモジュレートするための方法および組成物 |
| JP2023113050A Pending JP2023119040A (ja) | 2016-09-07 | 2023-07-10 | 遺伝子発現をモジュレートするための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023113050A Pending JP2023119040A (ja) | 2016-09-07 | 2023-07-10 | 遺伝子発現をモジュレートするための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US20190255106A1 (enExample) |
| EP (1) | EP3510152A4 (enExample) |
| JP (2) | JP7682604B2 (enExample) |
| CN (1) | CN109890962A (enExample) |
| AU (2) | AU2017324550B2 (enExample) |
| CA (1) | CA3035910A1 (enExample) |
| WO (4) | WO2018049073A1 (enExample) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9340800B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | Extended DNA-sensing GRNAS |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| US11680268B2 (en) | 2014-11-07 | 2023-06-20 | Editas Medicine, Inc. | Methods for improving CRISPR/Cas-mediated genome-editing |
| CA2986310A1 (en) | 2015-05-11 | 2016-11-17 | Editas Medicine, Inc. | Optimized crispr/cas9 systems and methods for gene editing in stem cells |
| WO2016201047A1 (en) | 2015-06-09 | 2016-12-15 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for improving transplantation |
| EP3786294A1 (en) | 2015-09-24 | 2021-03-03 | Editas Medicine, Inc. | Use of exonucleases to improve crispr/cas-mediated genome editing |
| EP4434589A3 (en) | 2015-10-23 | 2025-05-14 | President and Fellows of Harvard College | Evolved cas9 proteins for gene editing |
| US11597924B2 (en) | 2016-03-25 | 2023-03-07 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
| WO2017180694A1 (en) | 2016-04-13 | 2017-10-19 | Editas Medicine, Inc. | Cas9 fusion molecules gene editing systems, and methods of use thereof |
| CN109843914B (zh) | 2016-07-06 | 2024-03-15 | 沃泰克斯药物股份有限公司 | 用于治疗疼痛相关病症的材料和方法 |
| US11801313B2 (en) | 2016-07-06 | 2023-10-31 | Vertex Pharmaceuticals Incorporated | Materials and methods for treatment of pain related disorders |
| JP7231935B2 (ja) | 2016-08-03 | 2023-03-08 | プレジデント アンド フェローズ オブ ハーバード カレッジ | アデノシン核酸塩基編集因子およびそれらの使用 |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| EP3500675A4 (en) | 2016-08-19 | 2020-01-29 | Whitehead Institute for Biomedical Research | Methods of editing dna methylation |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| WO2018049073A1 (en) | 2016-09-07 | 2018-03-15 | Flagship Pioneering, Inc. | Methods and compositions for modulating gene expression |
| AU2017342543B2 (en) | 2016-10-14 | 2024-06-27 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
| US20200149039A1 (en) | 2016-12-12 | 2020-05-14 | Whitehead Institute For Biomedical Research | Regulation of transcription through ctcf loop anchors |
| WO2018119010A1 (en) | 2016-12-19 | 2018-06-28 | Editas Medicine, Inc. | Assessing nuclease cleavage |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| WO2018129368A2 (en) | 2017-01-06 | 2018-07-12 | Editas Medicine, Inc. | Methods of assessing nuclease cleavage |
| FI3565891T3 (fi) | 2017-01-09 | 2023-07-04 | Whitehead Inst Biomedical Res | Menetelmiä geeniekspression muuttamiseksi häiritsemällä säätelysilmukoita muodostavia transkriptiotekijämultimeerejä |
| AU2018218280B2 (en) | 2017-02-07 | 2024-10-17 | The Regents Of The University Of California | Gene therapy for haploinsufficiency |
| US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| CN110662556A (zh) | 2017-03-09 | 2020-01-07 | 哈佛大学的校长及成员们 | 癌症疫苗 |
| JP2020510439A (ja) | 2017-03-10 | 2020-04-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | シトシンからグアニンへの塩基編集因子 |
| WO2018176009A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| EP3615672A1 (en) | 2017-04-28 | 2020-03-04 | Editas Medicine, Inc. | Methods and systems for analyzing guide rna molecules |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| EP3635104A1 (en) | 2017-06-09 | 2020-04-15 | Editas Medicine, Inc. | Engineered cas9 nucleases |
| WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
| US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
| WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
| KR20200121782A (ko) | 2017-10-16 | 2020-10-26 | 더 브로드 인스티튜트, 인코퍼레이티드 | 아데노신 염기 편집제의 용도 |
| SG11202004926WA (en) | 2017-12-01 | 2020-06-29 | Encoded Therapeutics Inc | Engineered dna binding proteins |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| JP7611702B2 (ja) * | 2018-05-06 | 2025-01-10 | エメンドバイオ インコーポレーテッド | ヘテロ接合性ｅｌａｎｅ遺伝子の対立遺伝子の差次的ノックアウト |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| AU2019291918B2 (en) | 2018-06-29 | 2025-06-12 | Editas Medicine, Inc. | Synthetic guide molecules, compositions and methods relating thereto |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| KR102712986B1 (ko) | 2018-08-23 | 2024-10-07 | 상가모 테라퓨틱스, 인코포레이티드 | 조작된 표적 특이적 염기 편집기 |
| CN112218877B (zh) | 2018-08-27 | 2025-07-25 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
| WO2020081598A1 (en) * | 2018-10-15 | 2020-04-23 | Flagship Pioneering Innovations V, Inc. | Disrupting genomic complex assembly in fusion genes |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| WO2020113135A1 (en) * | 2018-11-29 | 2020-06-04 | Flagship Pioneering Innovations V, Inc. | Methods of modulating rna |
| WO2020154500A1 (en) * | 2019-01-23 | 2020-07-30 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020176553A1 (en) * | 2019-02-25 | 2020-09-03 | Sense Therapeutics Inc. | Intracellular mutation targeting therapy |
| KR20210140819A (ko) * | 2019-03-18 | 2021-11-23 | 사운드 애그리컬쳐 컴퍼니 | 식물에서 유전자 발현의 프로그래밍가능한 후성적 제어 |
| MX2021011426A (es) | 2019-03-19 | 2022-03-11 | Broad Inst Inc | Metodos y composiciones para editar secuencias de nucleótidos. |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| BR112021024055A2 (pt) * | 2019-05-29 | 2022-02-08 | Encoded Therapeutics Inc | Composições e métodos para a regulação seletiva de gene |
| CA3154759A1 (en) * | 2019-09-23 | 2021-04-01 | Flagship Pioneering Innovations V, Inc. | Modulating genomic complexes |
| EP4048807A1 (en) * | 2019-09-23 | 2022-08-31 | Omega Therapeutics, Inc. | Compositions and methods for modulating apolipoprotein b (apob) gene expression |
| CA3147643A1 (en) | 2019-09-23 | 2021-04-01 | Omega Therapeutics, Inc. | Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (hnf4.alpha.) gene expression |
| US20220267756A1 (en) * | 2019-09-23 | 2022-08-25 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for modulating genomic complex integrity index |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| JP2022553855A (ja) * | 2019-11-06 | 2022-12-26 | エメンドバイオ・インコーポレイテッド | 長さが２１～３０ヌクレオチドのガイド配列を使用したヘテロ接合ｅｌａｎｅ遺伝子の対立遺伝子のさまざまなノックアウト |
| US12258599B2 (en) | 2019-11-06 | 2025-03-25 | Emendobio Inc. | Method to inactivate a mutant allele of an ELANE gene |
| US12435334B2 (en) | 2019-11-06 | 2025-10-07 | Emendobio Inc. | Differential knockout of an allele of a heterozygous ELANE gene-II |
| CA3157438A1 (en) * | 2019-11-22 | 2021-05-27 | David Michael EPSTEIN | Method and system for identifying and validating shared candidate antigens and shared antigen-specific t lymphocyte pairs |
| CN114981424A (zh) * | 2020-01-17 | 2022-08-30 | 尼祖姆贝公司 | 在染色质靶点处dna链断裂的诱导 |
| WO2021171688A1 (ja) * | 2020-02-26 | 2021-09-02 | イムラ・ジャパン株式会社 | 遺伝子ノックイン方法、遺伝子ノックイン細胞作製方法、遺伝子ノックイン細胞、がん化リスク評価方法、がん細胞製造方法、及びこれらに用いるためのキット |
| IL296024A (en) | 2020-03-04 | 2022-10-01 | Flagship Pioneering Innovations Vi Llc | Methods and compositions for modulating a genome |
| EP4118207A1 (en) | 2020-03-11 | 2023-01-18 | Omega Therapeutics, Inc. | Compositions and methods for modulating forkhead box p3 (foxp3) gene expression |
| WO2021216457A1 (en) * | 2020-04-24 | 2021-10-28 | Spinalcyte, Llc | Treatment of frontotemporal dementia using fibroblasts and products thereof |
| WO2021226558A1 (en) | 2020-05-08 | 2021-11-11 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| WO2022072546A2 (en) * | 2020-09-29 | 2022-04-07 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for inhibiting the expression of multiple genes |
| CN112301020B (zh) * | 2020-10-19 | 2024-04-12 | 复旦大学附属肿瘤医院 | Iii类脱氧核酶突变体及其制备方法与应用 |
| CN114621959B (zh) * | 2020-12-08 | 2023-05-26 | 中国科学院海洋研究所 | 一种编码牙鲆igf2可溶性蛋白的基因及蛋白重组表达方法与应用 |
| KR20240011120A (ko) * | 2020-12-22 | 2024-01-25 | 크로마 메디슨, 인크. | 후성유전학적 편집을 위한 조성물 및 방법 |
| EP4308153A4 (en) * | 2021-03-16 | 2025-12-17 | Massachusetts Gen Hospital | Compositions and methods for treating diseases associated with nucleoside repeat expansion |
| WO2023283359A2 (en) | 2021-07-07 | 2023-01-12 | Omega Therapeutics, Inc. | Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression |
| US20230116385A1 (en) * | 2021-08-30 | 2023-04-13 | Sachi Bioworks Inc. | Composition of a therapeutic oligomer |
| JP2024533311A (ja) | 2021-09-08 | 2024-09-12 | フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー | ゲノムを調節するための方法及び組成物 |
| JP2024534523A (ja) | 2021-09-21 | 2024-09-20 | スクライブ・セラピューティクス・インコーポレイテッド | 操作されたｃａｓｘリプレッサー系 |
| WO2023225349A2 (en) * | 2022-05-20 | 2023-11-23 | Helex Inc. | Tissue specific methods and compositions for gene editing |
| WO2023250429A2 (en) * | 2022-06-22 | 2023-12-28 | Flagship Pioneering Innovations V, Inc. | Combination therapies comprising myc modulation |
| EP4544054A2 (en) * | 2022-06-22 | 2025-04-30 | Flagship Pioneering Innovations V, Inc. | Formulations for modulating myc expression |
| EP4713453A1 (en) | 2023-05-15 | 2026-03-25 | nChroma Bio, Inc. | Compositions and methods for epigenetic regulation of hbv gene expression |
| WO2024238723A1 (en) | 2023-05-16 | 2024-11-21 | Omega Therapeutics, Inc. | Methods and compositions for modulating pcsk9 expression |
| WO2024238726A1 (en) | 2023-05-16 | 2024-11-21 | Omega Therapeutics, Inc. | Methods and compositions for modulating methylation of a target gene |
| WO2024243438A2 (en) | 2023-05-23 | 2024-11-28 | Omega Therapeutics, Inc. | Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression |
| WO2025019742A1 (en) | 2023-07-19 | 2025-01-23 | Omega Therapeutics, Inc. | Methods and compositions for modulating ctnnb1 expression |
| WO2025085423A1 (en) * | 2023-10-19 | 2025-04-24 | The Broad Institute, Inc. | Method of multi-locus crispri targeting with a single truncated guide |
| CN118773200B (zh) * | 2024-07-18 | 2025-06-10 | 华中科技大学同济医学院附属同济医院 | 一种ttc21b基因突变位点及其应用 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101880277A (zh) | 2003-04-24 | 2010-11-10 | 因塞特公司 | 作为金属蛋白酶抑制剂的氮杂螺烷衍生物 |
| WO2009146033A2 (en) | 2008-03-31 | 2009-12-03 | Sma Foundation | Compositions and methods for modulating smn activity |
| CN102325534B (zh) | 2008-12-18 | 2016-02-17 | 戴瑟纳制药公司 | 延长的dicer酶底物和特异性抑制基因表达的方法 |
| WO2010113037A1 (en) | 2009-04-03 | 2010-10-07 | Centre National De La Recherche Scientifique | Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elements |
| US8822663B2 (en) | 2010-08-06 | 2014-09-02 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2694686B2 (en) * | 2011-04-06 | 2023-07-19 | The University of Chicago | COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5mC) |
| US9234213B2 (en) * | 2013-03-15 | 2016-01-12 | System Biosciences, Llc | Compositions and methods directed to CRISPR/Cas genomic engineering systems |
| IL289396B2 (en) * | 2013-03-15 | 2023-12-01 | The General Hospital Coporation | Using truncated guide rnas (tru-grnas) to increase specificity for rna-guided genome editing |
| US20160186208A1 (en) | 2013-04-16 | 2016-06-30 | Whitehead Institute For Biomedical Research | Methods of Mutating, Modifying or Modulating Nucleic Acid in a Cell or Nonhuman Mammal |
| WO2015033293A1 (en) | 2013-09-04 | 2015-03-12 | Csir | Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression |
| US9526784B2 (en) * | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9925277B2 (en) | 2013-09-13 | 2018-03-27 | Modernatx, Inc. | Polynucleotide compositions containing amino acids |
| US20150376612A1 (en) | 2014-06-10 | 2015-12-31 | The General Hospital Corporation | CCCTC-Binding Factor (CTCF) RNA Interactome |
| US10286086B2 (en) | 2014-06-19 | 2019-05-14 | Modernatx, Inc. | Alternative nucleic acid molecules and uses thereof |
| US9816074B2 (en) * | 2014-07-25 | 2017-11-14 | Sangamo Therapeutics, Inc. | Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells |
| CA2956224A1 (en) * | 2014-07-30 | 2016-02-11 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| GB201418965D0 (enExample) | 2014-10-24 | 2014-12-10 | Ospedale San Raffaele And Fond Telethon | |
| DK3212789T3 (da) | 2014-10-31 | 2020-07-27 | Massachusetts Inst Technology | Massiv parallel kombinatorisk genetik til crispr |
| US11680268B2 (en) * | 2014-11-07 | 2023-06-20 | Editas Medicine, Inc. | Methods for improving CRISPR/Cas-mediated genome-editing |
| EP3221813A4 (en) * | 2014-11-20 | 2018-04-18 | Children's Medical Center Corporation | Methods relating to the detection of recurrent and non-specific double strand breaks in the genome |
| WO2016089920A1 (en) | 2014-12-01 | 2016-06-09 | The Broad Institute, Inc. | Method for in situ determination of nucleic acid proximity |
| US20170369855A1 (en) | 2014-12-24 | 2017-12-28 | Dana-Farber Cancer Institute, Inc. | Systems and methods for genome modification and regulation |
| WO2016115326A1 (en) * | 2015-01-15 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for modulating genome editing |
| US10023922B2 (en) | 2015-03-23 | 2018-07-17 | Whitehead Institute For Biomedical Research | Reporter of genomic methylation and uses thereof |
| KR102888521B1 (ko) | 2015-04-06 | 2025-11-19 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna |
| EP3087974A1 (en) * | 2015-04-29 | 2016-11-02 | Rodos BioTarget GmbH | Targeted nanocarriers for targeted drug delivery of gene therapeutics |
| US20170014449A1 (en) * | 2015-07-13 | 2017-01-19 | Elwha LLC, a limited liability company of the State of Delaware | Site-specific epigenetic editing |
| US20190005191A1 (en) | 2015-07-14 | 2019-01-03 | Whitehead Institute For Biomedical Research | Chromosome neighborhood structures and methods relating thereto |
| AU2016308339A1 (en) | 2015-08-18 | 2018-04-12 | Baylor College Of Medicine | Methods and compositions for altering function and structure of chromatin loops and/or domains |
| US20180245057A1 (en) | 2015-09-01 | 2018-08-30 | Dana-Farber Cancer Institute, Inc. | Systems and methods for selection of grna targeting strands for cas9 localization |
| US20190048340A1 (en) * | 2015-09-24 | 2019-02-14 | Crispr Therapeutics Ag | Novel family of rna-programmable endonucleases and their uses in genome editing and other applications |
| US20170130247A1 (en) | 2015-09-30 | 2017-05-11 | Whitehead Institute For Biomedical Research | Compositions and methods for altering gene expression |
| WO2017075406A1 (en) | 2015-10-29 | 2017-05-04 | Whitehead Institute For Biomedical Research | Transcription factor trapping by rna in gene regulatory elements |
| US11339442B2 (en) | 2015-12-14 | 2022-05-24 | The General Hospital Corporation | Methods of detecting insulator dysfunction and oncogene activation for screening, diagnosis and treatment of patients in need thereof |
| EP3416976A2 (en) * | 2016-02-16 | 2018-12-26 | Yale University | Compositions for enhancing targeted gene editing and methods of use thereof |
| GB201608000D0 (en) | 2016-05-06 | 2016-06-22 | Oxford Biodynamics Ltd | Chromosome detection |
| EP3500675A4 (en) * | 2016-08-19 | 2020-01-29 | Whitehead Institute for Biomedical Research | Methods of editing dna methylation |
| WO2018049073A1 (en) | 2016-09-07 | 2018-03-15 | Flagship Pioneering, Inc. | Methods and compositions for modulating gene expression |
| WO2018085460A2 (en) | 2016-11-02 | 2018-05-11 | Flagship Pioneering, Inc. | Compositions and methods for cell delivery |
| US20200149039A1 (en) | 2016-12-12 | 2020-05-14 | Whitehead Institute For Biomedical Research | Regulation of transcription through ctcf loop anchors |
| FI3565891T3 (fi) | 2017-01-09 | 2023-07-04 | Whitehead Inst Biomedical Res | Menetelmiä geeniekspression muuttamiseksi häiritsemällä säätelysilmukoita muodostavia transkriptiotekijämultimeerejä |
| US20210322577A1 (en) | 2017-03-03 | 2021-10-21 | Flagship Pioneering Innovations V, Inc. | Methods and systems for modifying dna |
| US20210254056A1 (en) | 2017-05-05 | 2021-08-19 | Camp4 Therapeutics Corporation | Identification and targeted modulation of gene signaling networks |
| WO2019036430A1 (en) | 2017-08-14 | 2019-02-21 | Camp4 Therapeutics Corporation | METHODS OF TREATING HEPATIC DISEASES |
| WO2019071054A1 (en) | 2017-10-04 | 2019-04-11 | The Broad Institute, Inc. | METHODS AND COMPOSITIONS FOR MODIFYING THE FUNCTION AND STRUCTURE OF BUCKLES AND / OR CHROMATIN DOMAINS |
| EP3587516B1 (en) | 2018-06-27 | 2024-05-22 | Ricoh Company, Ltd. | Ink, method of manufacturing acrylic resin particle, printing method, ink accommodating unit, and inkjet printing device |
| WO2020081598A1 (en) | 2018-10-15 | 2020-04-23 | Flagship Pioneering Innovations V, Inc. | Disrupting genomic complex assembly in fusion genes |
| WO2020113135A1 (en) | 2018-11-29 | 2020-06-04 | Flagship Pioneering Innovations V, Inc. | Methods of modulating rna |
| US20220267756A1 (en) | 2019-09-23 | 2022-08-25 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for modulating genomic complex integrity index |
| WO2021061698A1 (en) | 2019-09-23 | 2021-04-01 | Omega Therapeutics, Inc. | Methods and compositions for modulating frataxin expression and treating friedrich's ataxia |
| CA3154759A1 (en) | 2019-09-23 | 2021-04-01 | Flagship Pioneering Innovations V, Inc. | Modulating genomic complexes |
| US20230399640A1 (en) | 2020-09-24 | 2023-12-14 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for inhibiting gene expression |
| WO2022072546A2 (en) | 2020-09-29 | 2022-04-07 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for inhibiting the expression of multiple genes |
| CA3205133A1 (en) | 2020-12-15 | 2022-06-23 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for modulating myc expression |
-
2017
- 2017-09-07 WO PCT/US2017/050553 patent/WO2018049073A1/en not_active Ceased
- 2017-09-07 WO PCT/US2017/050556 patent/WO2018049075A1/en not_active Ceased
- 2017-09-07 JP JP2019533313A patent/JP7682604B2/ja active Active
- 2017-09-07 US US16/330,999 patent/US20190255106A1/en not_active Abandoned
- 2017-09-07 AU AU2017324550A patent/AU2017324550B2/en active Active
- 2017-09-07 CA CA3035910A patent/CA3035910A1/en active Pending
- 2017-09-07 EP EP17849560.2A patent/EP3510152A4/en active Pending
- 2017-09-07 CN CN201780066156.1A patent/CN109890962A/zh active Pending
- 2017-09-07 WO PCT/US2017/050558 patent/WO2018049077A1/en not_active Ceased
- 2017-09-07 WO PCT/US2017/050561 patent/WO2018049079A1/en not_active Ceased
- 2017-11-22 US US15/821,632 patent/US11312955B2/en active Active
-
2018
- 2018-10-09 US US16/155,688 patent/US11624065B2/en active Active
-
2022
- 2022-03-18 US US17/698,917 patent/US12522823B2/en active Active
- 2022-03-18 US US17/698,912 patent/US12509683B2/en active Active
-
2023
- 2023-07-10 JP JP2023113050A patent/JP2023119040A/ja active Pending
-
2024
- 2024-06-11 AU AU2024203956A patent/AU2024203956A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019531763A5 (enExample) | ||
| TWI880645B (zh) | 抑制lpa之基因表現之組合物及方法 | |
| US11136597B2 (en) | Compositions for enhancing targeted gene editing and methods of use thereof | |
| JP2016513976A5 (enExample) | ||
| US20210322577A1 (en) | Methods and systems for modifying dna | |
| US20200308590A1 (en) | Compositions and methods for treatment of cystic fibrosis | |
| TW201920227A (zh) | 用於抑制脂蛋白元C-III (APOC3)表現之RNAi試劑及組合物 | |
| CA3035910A1 (en) | Methods and compositions for modulating gene expression | |
| US20180312839A1 (en) | Methods and compositions for increasing smn expression | |
| EP3573618B1 (en) | Compositions and methods for hemoglobin production | |
| JP2010515707A5 (enExample) | ||
| CN104769112A (zh) | 用于在细胞中表达蛋白质的方法和产品 | |
| WO2021061815A1 (en) | COMPOSITIONS AND METHODS FOR MODULATING HEPATOCYTE NUCLEAR FACTOR 4-ALPHA (HNF4α) GENE EXPRESSION | |
| ES2291536T3 (es) | Control de la expresion de gen usando un complejo de un oligonucleotido y un peptido regulatorio. | |
| JP2022512739A (ja) | 操作された長鎖散在反復エレメント（ｌｉｎｅ）トランスポゾンおよびそれらの使用方法 | |
| WO2021183720A1 (en) | Compositions and methods for modulating forkhead box p3 (foxp3) gene expression | |
| US20240279687A1 (en) | Peptide nucleic acids for spatiotemporal control of crispr-cas binding | |
| CA3097914A1 (en) | Methods of gene therapy | |
| JP2020521491A5 (enExample) | ||
| JP2024530169A (ja) | 方法 | |
| US20220243211A1 (en) | Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof | |
| JPWO2021189104A5 (enExample) | ||
| US20220372474A1 (en) | Hydroxymethyl-modified gamma-pna compositions and methods of use thereof | |
| CN115317610A (zh) | 基于vps9d1-as1靶点的aso药物在肿瘤治疗中的应用 | |
| WO2022250072A1 (ja) | 心疾患治療薬 |